Holen Sie sich die Stockscreener-App
47.17
0.84%
-0.40
Handel nachbörslich:
47.78
0.61
+1.29%
Schlusskurs vom Vortag:
$47.57
Offen:
$48.45
24-Stunden-Volumen:
1.33M
Relative Volume:
0.65
Marktkapitalisierung:
$5.83B
Einnahmen:
$692.26M
Nettoeinkommen (Verlust:
$-512.41M
KGV:
-11.12
EPS:
-4.24
Netto-Cashflow:
$-274.36M
1W Leistung:
-2.26%
1M Leistung:
+39.72%
6M Leistung:
+48.57%
1J Leistung:
+112.57%
1-Tages-Spanne:
$46.84
$48.45
1-Wochen-Bereich:
$44.10
$50.89
52-Wochen-Spanne:
$15.81
$50.89
Guardant Health Inc Stock (GH) Company Profile
Firmenname
Guardant Health Inc
Sektor
Branche
Telefon
855-698-8887
Adresse
3100 HANOVER STREET, PALO ALTO
Vergleichen Sie GH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GH
Guardant Health Inc
|
47.17 | 5.83B | 692.26M | -512.41M | -274.36M | -4.24 |
|
TMO
Thermo Fisher Scientific Inc
|
580.57 | 222.07B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
215.01 | 154.61B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
147.04 | 41.95B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IDXX
Idexx Laboratories Inc
|
465.03 | 38.08B | 3.84B | 866.24M | 792.60M | 10.37 |
|
IQV
Iqvia Holdings Inc
|
200.04 | 36.31B | 15.32B | 1.41B | 1.96B | 7.62 |
Guardant Health Inc Stock (GH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-23 | Eingeleitet | Barclays | Overweight |
| 2024-06-28 | Hochstufung | Guggenheim | Neutral → Buy |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-04-24 | Fortgesetzt | Craig Hallum | Buy |
| 2023-12-14 | Eingeleitet | Guggenheim | Neutral |
| 2023-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2023-11-13 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-09-27 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-05-26 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-05-05 | Eingeleitet | UBS | Buy |
| 2023-03-09 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-11-01 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-10-19 | Eingeleitet | Craig Hallum | Buy |
| 2022-10-06 | Eingeleitet | Stephens | Overweight |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-06-03 | Eingeleitet | Piper Sandler | Overweight |
| 2022-04-28 | Fortgesetzt | BTIG Research | Buy |
| 2022-02-24 | Bestätigt | Canaccord Genuity | Buy |
| 2022-02-24 | Bestätigt | Citigroup | Buy |
| 2022-02-24 | Bestätigt | Cowen | Outperform |
| 2022-02-24 | Bestätigt | Morgan Stanley | Overweight |
| 2022-02-24 | Bestätigt | SVB Leerink | Outperform |
| 2022-02-24 | Bestätigt | Stifel | Buy |
| 2022-02-24 | Bestätigt | Wells Fargo | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-15 | Eingeleitet | Raymond James | Mkt Perform |
| 2021-06-03 | Eingeleitet | Goldman | Buy |
| 2021-05-25 | Eingeleitet | Wells Fargo | Overweight |
| 2021-01-11 | Eingeleitet | Stifel | Buy |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-06-12 | Eingeleitet | BTIG Research | Buy |
| 2020-02-21 | Eingeleitet | Guggenheim | Buy |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-08-07 | Bestätigt | Canaccord Genuity | Buy |
| 2019-04-16 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-04-10 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-02-28 | Bestätigt | BofA/Merrill | Neutral |
| 2018-10-29 | Eingeleitet | BofA/Merrill | Neutral |
| 2018-10-29 | Eingeleitet | JP Morgan | Overweight |
| 2018-10-29 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Guardant Health Inc Aktie (GH) Neueste Nachrichten
Guardant Health (NASDAQ:GH) Sets New 12-Month HighWhat's Next? - MarketBeat
Guardant Health (NASDAQ:GH) Trading Down 5.7%Should You Sell? - MarketBeat
Guardant Health, Inc. (NASDAQ:GH) Shares Sold by SG Americas Securities LLC - MarketBeat
Why Guardant Health, Inc. (GH) Is Among the Best Booming Stocks to Invest in Now? - Insider Monkey
Exchange Traded Concepts LLC Decreases Stock Position in Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
12 Best Booming Stocks to Invest in Now - Insider Monkey
The Goldman Sachs Group Raises Guardant Health (NASDAQ:GH) Price Target to $49.00 - MarketBeat
Guardant Health (NASDAQ:GH) Given New $49.00 Price Target at The Goldman Sachs Group - MarketBeat
Abu Dhabi selects Guardant Health’s Shield Test for blood-based colorectal cancer screening programme - BSA bureau
Guardant Health stock soars to 52-week high of $49.97 - MSN
Guardant Health to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025 - Milton Daily Standard
Guardant Health stock soars to 52-week high of $49.97 By Investing.com - Investing.com Nigeria
Guardant Health Selected by Abu Dhabi Health Department to Launch Colorectal Cancer Screening Program - Marketscreener.com
Guardant Health Secures Landmark Deal: 10,000 Cancer Screenings Set for Abu Dhabi - StockTitan
Okla And Rigetti Computing Are Among Top 8 Mid Cap Gainers Last Week (Jan 20-Jan 24): Are The Others In Your Portfolio? - Benzinga
Why Guardant Health (GH) Is Skyrocketing Now - Insider Monkey
Guardant Health (NASDAQ:GH) Stock Price Up 6.4%What's Next? - MarketBeat
Guardant Health stock target raised to $55 by BTIG - MSN
Barclays Initiates Coverage of Guardant Health (GH) with Overweight Recommendation - MSN
Leerink Partnrs Weighs in on Guardant Health Q4 Earnings - Defense World
Barclays initiates Guardant Health stock with Overweight rating By Investing.com - Investing.com Canada
Guardant Reveal aids organ preservation in rectal cancer treatment - Investing.com India
Barclays Begins Coverage on Guardant Health (NASDAQ:GH) - MarketBeat
Barclays initiates Guardant Health stock with Overweight rating - Investing.com
Q4 EPS Estimate for Guardant Health Increased by Analyst - MarketBeat
Guardant Health to Present Major Cancer Detection Breakthroughs at ASCO GI 2025 Symposium - StockTitan
Why Guardant Health, Inc. (GH) Soared At The Start Of The Trading Week - MSN
Guardant Health (NASDAQ:GH) Shares Up 6.4%Here's Why - MarketBeat
Guardant Health's (GH) "Buy" Rating Reaffirmed at Guggenheim - MarketBeat
Guardant Health stock hits 52-week high of $39.61 amid growth - Investing.com Australia
Wealthcare Advisory Partners LLC Takes $252,000 Position in Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
Guardant Health, Inc.'s (NASDAQ:GH) P/S Is Still On The Mark Following 43% Share Price Bounce - Simply Wall St
Guardant stock jumps 12% on Medicare coverage expansion - MSN
Guardant Health director Tariq Musa sells shares worth $4,359 - MSN
Raymond James maintains Outperform on Guardant Health, $39 target - MSN
Why Top 4% Guardant Health Surged To A 13-Month High And Topped A Profit-Taking Zone - MSN
Why This Top 4% Cancer-Tied Stock Just Hit A 13-Month High - Investor's Business Daily
Canaccord maintains Guardant Health stock Buy rating and $42 target - MSN
Guardant Health Gains Medicare Coverage For Colorectal Cancer Monitoring Test - Yahoo Finance
Finanzdaten der Guardant Health Inc-Aktie (GH)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.26%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):